Kanglin Biotech

About:

Kanglin Biotech is a national high-tech company that create first- and best-in-class revolutionary gene therapies.

Website: https://www.kanglinbio.com

Top Investors: Biomedicine and High-end Equipment Industry Fund, Hangzhou Miyin Investment Management

Description:

Kanglin Biotech is a national high-tech company that create first- and best-in-class revolutionary gene therapies.Kanglin Biopharma specializes in the discovery, development, and commercialization of novel gene therapy treatments for diseases that adversely impair human health, including as thalassemia, AIDS, hemophilia, and Parkinson's disease.

Total Funding Amount:

150M CNY

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2015-01-01

Founders:

Number of Employees:

Last Funding Date:

2024-11-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai